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Abstract
Purpose—Little is known about gender differences in the treatment of pain after motor vehicle 
collisions (MVCs) in the emergency department (ED). We aimed to describe gender differences in 
pain experiences and treatment, specifically the use of opioids and benzodiazepines after ED 
discharge, for MVC-related pain.
Methods—This was a secondary analysis of previously collected data from the CRASH studies. 
We included patients who were seen and discharged from the Emergency Department (ED) after a 
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MVC and who were enrolled in one of two multicenter longitudinal prospective cohort studies 
(one Black/Non-Hispanic and one White/Non-Hispanic). First, we compared the experience of 
pain as defined by self-reported moderate to severe axial pain, widespread pain, number of somatic 
symptoms, pain catastrophizing, and peritraumatic distress between women and men using 
bivariate analyses. We then determined if there were gender differences in the receipt of 
prescription medications for post-MVC pain symptoms (opioids and benzodiazepines) using 
mutlivariate logistic regression adjusting for demographics, pain, and collision characteristics.
Findings—In total, 1878 patients were included: 61.4% were women. More women reported 
severe symptoms on the pain catastrophizing scale (36.8% vs. 31.0%, p=0.032) and peritraumatic 
distress following the MVC (59.7% vs. 42.5%, p<0.001), and women reported more somatic 
symptoms than men (median 3.9, IQR 3.7–4.0 vs. 3.3, IQR 3.1–3.5, p<0.001). Unadjusted, similar 
proportions of women and men were given opioids (29.2% vs. 29.7%, p=0.84). After adjusting for 
covariates, women and men remained equally likely to receive a prescription for opioids (RR 0.83, 
95%CI 0.58–1.19). Women, however, were less likely than men to receive a benzodiazepine at 
discharge (RR 0.53, 95%CI 0.32–0.88).
Implications—In a large, multicenter study of ED patients treated for MVC, there were gender 
differences in the acute psychological response to MVC with women reporting more 
psychological and somatic symptoms. Women and men were equally likely to receive opioid 
prescriptions at discharge. Future research should investigate potential gender-specific 
interventions to reduce both post-traumatic distress and the risk of developing negative long-term 
outcomes like chronic pain.
Keywords
gender; pain; opioids; gender differences
INTRODUCTION
Injuries related to motor vehicle collisions (MVCs) account for over 4 million emergency 
department (ED) visits every year.1 Post-traumatic musculoskeletal pain resulting from 
MVCs has potential negative outcomes including persistent pain (pain that lasts beyond the 
expected normal recovery time)2 and even chronic widespread pain,3 a condition associated 
with decreased physical independence as well as a lower quality of life.4
Based on literature supporting gender differences in a range of painful conditions such as 
headache, chronic pain syndromes, and musculoskeletal pain,5 gender differences in post-
traumatic pain may also exist.6, 7 Differences in pain between women and men across 
conditions are extensive and include differences in the severity and intensity of reported 
pain, pain sensitivity, prevalence of chronic pain, pain-associated distress and anxiety, and 
pain-induced hyperalgesia. 5, 6, 8–10 In addition, previous data have shown gender 
differences in both the receipt of analgesic treatment in the emergency department and in the 
response to treatment that is given (e.g., opioids). 5, 11–1314, 15 Potential gender differences 
in pain perception, experience, treatment, and outcomes after MVCs could have important 
implications on the development of chronic pain and related outcomes following a traumatic 
event.
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Post-traumatic pain is often treated with opioids after ED discharge,16 and musculoskeletal 
pain (including that resulting from trauma) treated in the ED or primary care setting is often 
treated with opioids and/or benzodiazepines.17, 18 Some data also suggest that there are 
increased rates of benzodiazepine use among patients in the months following a MVC.19 
Given the large number of opioids being prescribed in the U.S.20 and the high prevalence of 
substance use disorders related to prescription opioid and benzodiazepines,20 it is especially 
important to understand whether there are gender differences in the treatment response, 
outcomes of post-traumatic pain including persistent or chronic pain, or in effects of opioid 
and/or benzodiazepine use among those treated for pain from MVCs. Though not specific to 
post-traumatic pain, data do show that prescriptions for benzodiazepines, which have the 
potential for abuse and long-term withdrawal, are approximately twice as common in 
women than men across all clinical indications.21
Before we can adequately explore gender differences in the long-term outcomes of post-
traumatic pain and the response of post-traumatic pain to opioids and other classes of 
medications, we must first better characterize gender differences in acute post-traumatic pain 
and its treatment.
Objectives
We aimed to describe gender differences in pain and in the prescription of opioids and 
benzodiazepines following a MVC. First, we described gender differences in pain 
experiences among patients presenting to the ED with isolated musculoskeletal pain after a 
MVC. Next, we compared crude rates of opioid and benzodiazepine prescriptions after 
MVC between women and men. Finally, we evaluated whether patient gender was 
associated with differential prescribing, specifically receipt of an opioid or benzodiazepine 
at discharge, after adjusting for pain, demographics, and collision characteristics.
PATIENTS AND METHODS
Study Population/Setting
The CRASH project is a prospective, multicenter, observational cohort study funded by the 
NIH to study predictors of acute and chronic musculoskeletal pain following minor MVCs.
22
 This is a secondary analysis of previously collected data from two cohorts of the CRASH 
study, one of white/non-Hispanic patients (the European American (EA) cohort) and one of 
Black/non-Hispanic patients (the African-American (AA) cohort), both previously enrolled 
in one of two longitudinal prospective studies of patients seen and discharged from the ED 
after a MVC. Details of the original study methods have been previously published. 2, 22, 23 
In brief, participants were screened and enrolled by trained research assistants. Screening 
occurred during day and evening hours based on availability of research assistants and 
occurred for approximately 12 to 16 hours each day at each site.22, 23 Data were collected by 
trained research assistants during the ED visit using patient interview; additional data were 
collected from the medical record following the completion of the ED visit.
For the EA cohort, patients 18 to 65 years old presenting to one of 8 participating EDs 
across 4 states (Florida, Massachusetts, Michigan, and New York) within 24 hours of a 
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MVC from February 2009 to October 2011 were eligible for enrollment. For the AA cohort, 
patients 18 to 65 years old presenting to one of 13 participating EDs across 7 states 
(Alabama, Florida, Michigan, Pennsylvania, Washington, D.C., Massachusetts, New Jersey) 
within 24 hours of a MVC from 2012 to 2016 were eligible for enrollment. In both cohorts, 
patients were excluded if they were admitted to the hospital, had fractures with the exception 
of phalanx fractures, had four or more lacerations requiring sutures or one laceration greater 
than 20 centimeters long, or had intracranial or spinal injuries. If patients were not alert and 
oriented, were pregnant, were inmates, or were not fluent in English, they were also 
excluded. Finally, patients were excluded if they were currently taking at least 20 mg of 
oxycodone or an equivalent dose of another opioid. The study was IRB approved at each site 
and informed consent was obtained from all enrolled patients. The research was conducted 
in accordance with the Code of Ethics of the World Medical Association (Declaration of 
Helsinki).
The initial EA cohort study was powered to assess genetic predictors of acute and chronic 
musculoskeletal pain following a MVC with a planned enrollment of 936 participants;22 
enrollment for the subsequent AA cohort study was powered based on the EA cohort.23
Outcomes/Definitions
Our first outcome was pain experience by gender. Data on several measures of pain 
experience were collected: pain intensity (numerical pain scores), presence of widespread 
pain (axial pain plus pain in an upper and lower segment plus pain on the left- and right-
side), presence of moderate to severe axial pain (pain in the neck, back or shoulders rated as 
4 or greater on a 10 point numerical rating scale), number of somatic symptoms (of 10 
common post-traumatic symptoms, number of symptoms whose severity was rated equal to 
or greater than 1 on a 10-point numerical rating scale), score on the pain catastrophizing 
scale24, 25 (a 13- item scale that assesses fear, anxiety, and helplessness in response to pain), 
peritraumatic distress (score of 23 or greater on the Peritraumatic Distress Inventory26, 27), 
and attitude regarding likelihood of recovery (measured by an item on the Life Orientation 
Test-Revised survey28 asking participants how sure they are that they will fully recover from 
the accident). Survey instruments for pain catastrophizing,24 peritraumatic distress,27 and 
attitude regarding likelihood of recovery28 have each been previously validated.” 
Widespread pain, moderate to severe axial pain, number of somatic symptoms, score on the 
Pain Catastrophizing Scale, peritraumatic distress, and likelihood of recovery were measured 
during the initial ED visit following the MVC.
Our next outcome measure, treatment of pain, was operationalized using data on 
prescriptions for opioid or benzodiazepines medications given to the participant at time of 
discharge from the ED. Medications categorized as opioid agonists included oxycodone, 
hydrocodone, or combination medications including oxycodone or hydrocodone. These two 
medications comprise > 95% of all opioid prescriptions in our database, and lesser 
prescribed opioids were excluded from this analysis (e.g., tramadol, codeine, 
hydromorphone). Medications categorized as benzodiazepines included diazepam, 
lorazepam, alprazolam, and clonazepam.
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Statistical analyses
First, baseline descriptive data on demographics (age, race, marital status, body mass index 
(BMI), smoking status, highest level of education completed, annual income, employment 
status) and collision characteristics (extent of vehicle damage during MVC, driver vs. 
passenger, speed of collision, and seat belt use) were reported by gender. Unless otherwise 
specified, all analyses were conducted in the combined EA and AA cohorts.
Next, to compare pain experience by gender, we used bivariate analyses to compare each 
measure of pain experience. Report of widespread pain, moderate to severe axial pain, pain 
catastrophizing score, attitude toward likelihood of recovery, and peritraumatic distress were 
compared between women and men using chi-square tests. Number of somatic symptoms 
were compared by gender using students’ t-tests. In additional analyses, we stratified the 
entire sample by cohort (EA and AA) and then reported outcomes by gender. Within each 
race cohort, women and men were compared with regard to pain experiences (widespread 
pain, moderate to severe axial pain, number of somatic symptoms, severe symptoms on the 
pain catastrophizing scale, peritraumatic distress, and attitude towards likelihood of 
recovery).
To analyze receipt of opioids or benzodiazepines at time of ED discharge, we first conducted 
unadjusted analyses comparing the proportion of women versus men who received 
prescriptions for: 1) opioids and 2) benzodiazepines at the time of discharge from the ED 
using chi-square tests. These gender-based comparisons were compared in the overall 
sample and then in the sample stratified by cohort (EA and AA).
To assess whether confounders affected the treatment of pain in women vs. men, we 
performed multivariate logistic regression, using receipt of an opioid prescription as the 
outcome and gender as the primary predictor variable. Based on scientific plausibility of 
factors associated with opioid use for pain after MVC, the model was adjusted a priori for 
age, race (Black/non-Hispanic or white/non-Hispanic), highest level of education completed 
(less than high school, some college, completion of college or graduate school), income 
(divided into $20,000 increments), employment status (unemployed, student, part-time, full-
time, disabled), body mass index (BMI), cigarette use (yes/no), baseline depression 
(measured on Center for Epidemiologic Depression (CES-D) scale), partner status (married, 
serious relationship and cohabitating, serious relationship and not cohabitating, no serious 
relationship), extent of damage to vehicle (none/minor, moderate, severe), seatbelt use (yes/
no), speed of MVC, passenger vs. driver, moderate to severe axial pain, number of somatic 
symptoms, and peritraumatic distress. Variables were operationalized as above; speed of 
MVC was treated as a continuous variable. A similar multivariate logistic regression was 
then performed with receipt of benzodiazepines as the outcome, adjusting for the same 
factors. Race-by-gender interaction terms were tested in each model and kept based on 
significance determined in likelihood ratio testing. For all logistic regression models, 
adjusted odds ratios (OR) with 95% CI were reported. In all analyses, p-values < 0.05 were 
considered statistically significant. All statistical analyses were performed using Stata 
software v.14.0 (Stata Corporation, College Station, TX.)
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RESULTS
In total, 1878 patients were included; 61.4% (n=1153) were women, 49.5% (n=930) were 
black, and overall median age was 32 (IQR 24–46). Table 1 describes demographic 
characteristics and collision characteristics by gender. Women and men were similar in 
terms of age and race yet differed with regard to factors including completed education, 
income, partner status, and cigarette use. In terms of collision characteristics, more women 
than men reported seatbelt use (91.8% vs. 84.0%), but women and men were similar with 
respect to the extent of vehicle damage and whether they were the driver or passenger.
Table 2 shows pain experiences in women compared with men. Overall, women and men 
were similar with respect to report of widespread pain, moderate to severe axial pain, and 
attitudes regarding likelihood of recovery. In contrast, women reported more somatic 
symptoms (3.9 vs. 3.3, p<0.001), and more women than men reported peritraumatic distress 
(59.7% vs. 42.5%, p,0.001) and “severe” symptoms on the pain catastrophizing scale (55.2% 
v. 27.5%, p=0.011).
Following stratification by race cohort (EA and AA) (Table 3), pain experience differed 
between women and men in the EA cohort but not in the AA cohort. Compared to EA men, 
EA women had more widespread pain, more moderate to severe axial pain, more somatic 
symptoms, more severe pain on the pain catastrophizing scale, and more peritraumatic 
distress. In the AA cohort, compared to men, women had more peritraumatic distress; all 
other pain experiences were similar by gender.
With respect to treatment of pain at ED discharge, in unadjusted analyses, similar 
proportions of women and men received a prescription for opioids (29.2% vs. 29.7%, 
p=0.84) (Table 2). Similar numbers of women and men also received benzodiazepines (9.3% 
vs. 11.6%, p=0.11) at time of discharge. Table 2 also shows that similar numbers of women 
vs. men were given opioids or benzodiazepines during their ED stay. In the sample stratified 
by cohort (EA and AA), there were no gender differences in the receipt of either opioid or 
benzodiazepine prescriptions in either cohort (Table 3). There was, however, a difference in 
receipt of opioids during the ED stay in the AA cohort but not the EA cohort (Table 3) in 
unadjusted analyses.
Table S1 displays the results of our multivariate analysis of receipt of an opioid prescription 
at discharge. After adjusting for demographic factors, collision characteristics, pain 
(moderate to severe axial pain), somatic symptoms, peritraumatic distress, and depression, 
women and men were equally likely to receive a prescription for opioids at the time of 
discharge (RR 0.83, 95%CI 0.58–1.19). Increasing age (RR 1.01, 95%CI 1.00–1.02) and 
moderate to severe axial pain (RR 1.95, 95%CI 1.40–2.75) increased the likelihood of 
receiving an opioid prescription, while black race (RR 0.19, 95%CI 0.07–0.50) and seatbelt 
use (RR 0.59, 95%CI 0.39–0.92) decreased the likelihood of receiving an opioid 
prescription. Table S2 shows the results of our multivariate analysis of receipt of a 
benzodiazepine prescription at discharge. After adjustment, women were less likely than 
men to receive benzodiazepines at discharge (RR 0.53, 95%CI 0.32–0.88). Other significant 
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predictors included BMI, partner status, and moderate to severe axial pain. Race-by-gender 
interaction terms were not significant in either of these logistic regression models.
DISCUSSION
In our analysis of patients with minor injuries seen in the ED after a MVC, pain experiences 
differed between women and men, specifically with respect to their acute psychological 
responses. More women reported psychological distress, depression, somatic symptoms, and 
pain catastrophizing compared with men. Though there were no differences in pain severity 
between women and men in the overall sample, white/Non-Hispanic women had more 
severe pain compared with white/Non-Hispanic men; no such gender difference existed in 
the Black/Non-Hispanic cohort; this suggests that there may in fact be differences in pain 
severity after MVC by gender, but that it differs by race. Despite gender differences in the 
experience of pain and the acute psychological response, women and men were equally 
likely to receive opioid pain medications at discharge after adjusting for pain, pain-related 
distress, various demographic factors, social determinants, and collision characteristics. It is 
possible that there were unmeasured differences between the EA and AA cohort and that the 
association between gender and receipt of pain medications at discharge differs across racial 
strata, though our preliminary analyses do not largely support this. Finally, women, however, 
were less likely to receive a prescription for benzodiazepines, a somewhat surprising finding 
given previous literature that women are more likely to be prescribed anxiolytics in both 
outpatient and ED settings.21, 29
Our finding that women were more likely to report psychological sequelae after a MVC is 
consistent with prior data showing that women and men differ with respect to their acute 
psychological responses to pain.6, 10 Acute psychological responses to pain have the 
potential to cause more severe acute pain and may lead to an increased risk of persistent 
and/or chronic pain,30, 31 which is known to be more common in women than men.32, 33 It is 
critical for physicians to recognize and address such acute psychological responses during 
the ED visit by treating pain, providing reassurance, and factoring in psychosocial issues 
that may affect a patient’s ability to cope with pain and distress following a MVC. 
Furthermore, some data have indicated that gender may affect the response to pharmacologic 
and non-pharmacologic interventions for pain,34, 35 but this needs to be investigated further, 
especially with respect to reduction of post-traumatic distress and pain catastrophizing. Our 
findings, while showing no significant gender difference in use of prescription opioids upon 
ED discharge after MVC, suggest the need for future research investigating both reasons for 
more pain-related psychological distress in women as well as possible gender-specific 
interventions to prevent the development of psychological distress following MVCs. Future 
research should also evaluate long-term outcomes in women vs. men after MVC and how 
initial treatment in the ED may impact those outcomes and perhaps differentially with 
respect to men and women.
Despite more distress exhibited by women compared with men after MVCs, women in our 
study were less likely to receive benzodiazepines at discharge. It is plausible that 
benzodiazepines in this setting would likely be prescribed because of their muscle relaxant 
properties rather than their sedative or anxiolytic actions.18 Our findings may differ from 
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previous studies that show higher rates of benzodiazepine use in women across a wide range 
of clinical indications21 because our sample was limited to patients being seen for post-
traumatic pain. Physicians may be less likely to use benzodiazepines for women with post-
traumatic pain and distress if they believe the symptoms are time-limited, if the post-
traumatic distress and anxiety is not recognized, or if they believe alternative interventions 
would be more effective. These hypotheses would have to be tested in future research.
Our findings also conflict to some degree with prior literature indicating that women are at 
risk for oligoanalgesia when being seen in the ED for pain-related conditions. For example, 
one study of almost 1000 patients with non-traumatic abdominal pain in the ED reported 
that even after adjusting for age, race, triage designation, and pain score, women were 13 to 
25% less likely to receive opioid analgesia and had longer delays to administration of any 
pain medication.15 Our findings that women and men were equally likely to receive opioids 
may reflect differences in treatment of pain due to other pain complaints versus post-
traumatic musculoskeletal pain or perhaps practice differences in the enrolling sites.
Finally, though not the primary objective of this paper, we found that Black patients were 
less likely to receive opioid prescriptions. This is notable in light of data from a companion 
project on race and post-traumatic pain using CRASH data showing that participants in the 
AA cohort are over twice as likely to experience moderate to severe axial pain at 6 weeks 
post MVC and are also more likely to have more severe pain in the ED.36 Other notable 
differences by gender in our study include differences in demographics and crash 
characteristics. For example, women were less likely to report seatbelt use, a factor which 
deceased the likelihood of opioid prescriptions at discharge. Our findings of gender 
differences in seatbelt use is consistent with prior data and could point to the need for 
gender-specific education efforts to promote seatbelt use.37
There are some limitations to our study. First, it is possible that the two cohorts had 
differences that affected our findings. For example, the two cohort studies (EA and AA) 
were conducted during different study periods (2009–2011 and 2012–2016); it is possible 
that the results would have differed if the cohorts were conducted simultaneously. In our 
study, Black race was associated with lower rates of opioid prescriptions; given that opioid 
prescription rates have risen in recent years It is possible that any difference by race was 
underestimated. We only accounted for opioid and/or benzodiazepine prescriptions written 
at the initial ED visit following the MVC, yet it is possible that some patients received 
prescriptions from other physicians or in other healthcare settings after the initial ED visit. 
We also did not have access to data on provider gender, which has been shown in some 
studies to have even more effect than patient gender on the treatment of pain in the ED.38 
Additional limitations include a potential lack of generalizability of our results to other 
geographic regions (i.e., the western U.S.) and possible selection bias due to lack of 
inclusion of non-English speaking patients. Finally, we did not have data on number of pain 
or benzodiazepine pills prescribed, which could potentially be different between women and 
men.
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CONCLUSIONS
In our large, multicenter study of ED patients treated for minor MVC, there were gender 
differences in the acute psychological response to MVC with women reporting more 
psychological and somatic symptoms. Women and men were equally likely to receive opioid 
prescriptions at discharge in the overall sample even after adjusting for confounding factors.
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Table 1
Demographic and collision characteristics by gender
Women (n=1153) Men (n=725) Difference (95%CI)
Patient Demographics
Age 34.9 (34.2 – 35.7) 36.0 (35.1 – 37.0) 1.1 (−0.1 – 2.3)
Race (% black) 50.1 (578) 48.6 (352) −1.6 (−6.2 – 3.1)
Income
 <$20,000 25.0 (243) 21.2 (127) −3.8 (−8.1 – 0.4)
 $20,000 to $40,000 28.2 (274) 20.7 (124) −7.5 (−11.8 – −3.2)
 $40,000 to $80,000 29.1 (283) 31.3 (188) 2.2 (−2.5 – 6.9)
 >$80,000 17.7 (172) 26.8 (161) 9.1 (4.9 – 13.4)
Education complete
 High school or less 26.0 (299) 41.3 (297) 15.2 (10.8 – 19.6)
 Some college 40.3 (463) 39.7 (286) −0.6 (−5.1 – 4.0)
 College/post-graduate level 33.7 (387) 19.0 (137) −14.7 (−18.6 – −10.7)
Partner status
 Married 26.9 (310) 36.1 (261) 9.2 (4.9 – 13.5)
 Serious relationship, not living together 17.4 (200) 14.7 (106) −2.7 (−6.1 – 0.7)
 Serious relationship, living together 15.0 (173) 12.7 (92) −2.3 (−5.5 – 0.9)
 No serious relationship 39.7 (457) 35.4 (256) −4.3 (−8.7 – 0.2)
Employment status+
 Unemployed 15.6 (148) 14.6 (89) −1.0 (−4.6 – 2.7)
 Student 1.1 (10) 0.5 (3) −0.6 (0.4 – 1.7)
 Work part time 17.4 (165) 12.6 (77) −4.7 (−8.3 – 1.2)
 Work full time 64.9 (617) 71.6 (437) 6.8 (2.1 – 11.5)
 Disabled 1.2 (11) 0.7 (4) −0.5 (−1.4 – 0.4)
Cigarette use 23.2 (267) 31.9 (231) 8.7 (4.5 – 12.9)
Extent damage
 None/minor 28.5 (317) 29.3 (204) 0.8 (−3.5 – 5.1)
 Moderate 43.8 (487) 43.6 (304) −0.2 (−4.9 – 4.5)
 Severe 27.7 (308) 27.1 (189) −0.6 (−4.8 – 3.6)
Seatbelt 91.8 (1052) 84.0 (584) −7.8 (−10.9 – −4.6)
Passenger vs driver 78.8 (909) 76.9 (552) −2.0 (−5.8 – 1.9)
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Table 2
Experience and treatment of pain after motor vehicle collision by gender
Women Men P-value
Pain experience
Widespread Pain 24.2 (21.7 – 26.7) 21.2 (18.3 – 24.2) 0.139
Moderate to severe axial pain 76.0 (73.5 – 78.4) 72.6 (69.3 – 75.8) 0.097
Number of somatic symptoms 3.9 (3.7 – 4.0) 3.3 (3.1 – 3.5) <0.001
Pain catastrophizing scale 0.011
 None 2.0 (1.4 – 3.0) 3.0 (2.0 – 4.5)
 Mild 9.4 (7.8 – 11.1) 11.7 (9.5 – 14.3)
 Moderate 33.5 (30.8 – 36.3) 37.8 (34.3 – 41.5)
 Severe 55.2 (52.2 – 58.0) 47.5 (43.8 – 51.2)
Ces-D depression
 Yes 8.7 (7.0 – 10.3) 3.9 (2.5 – 5.3) <0.001
 No 91.3 (89.6 – 92.8) 96.1 (94.5 – 97.3) <0.001
Peritraumatic distress (>20) 59.7 (56.8 – 62.5) 42.5 (38.9 – 46.2) <0.001
Likelihood of recovery 89.0 (87.2 – 90.9) 89.7 (87.4 – 91.9) 0.678
Treatment
During ED visit
Proportion given opioids in the ED 20.6 (18.3 – 23.0) 17.8 (15.0 – 20.6) 0.130
Proportion given Benzos in the ED 6.4 (5.0 – 7.8) 6.3 (4.6 – 8.1) 0.950
At discharge
Proportion given opioids discharge 29.2 (26.6 – 31.9) 29.7 (26.3 – 33.0) 0.843
Proportion given benzodiazepines at discharge 9.3 (7.6 – 11.0) 11.6 (9.3 – 13.9) 0.108
Continuous data are presented as median (interquartile range (IQR). Categorical data are displayed as proportions (%) and 95% confidence 
intervals unless otherwise specified. P<0.05 was considered statistically significant.
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